Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum

• Main Authors: Cressey T., Stek A., Capparelli E., Bowonwatanuwong C., Prommas S., Sirivatanapa P., Yuthavisuthi P., Neungton C., Huo Y., Smith E., Best B., Mirochnick M.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859758788&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42883
• Institution: Chiang Mai University

Background: The impact of pregnancy on efavirenz (EFV) pharmacokinetics is unknown. Methods: International Maternal Pediatric Adolescent AIDS Clinical Trials P1026s is an on-going, prospective, nonblinded study of antiretroviral pharmacokinetics in HIV-infected pregnant women that included a cohort...